Abstract
Results of Venetoclax and Azacitidine Combination in Chemotherapy Ineligible Untreated Patients with Acute Myeloid Leukemia with IDH 1/2 Mutations
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have